Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation

被引:68
|
作者
Haines, David E. [1 ]
Wang, Yongfei [2 ]
Curtis, Jeptha [2 ]
机构
[1] Oakland Univ, Dept Cardiovasc Med, William Beaumont Sch Med, Beaumont Hosp,Heart Rhythm Ctr, Royal Oak, MI 48073 USA
[2] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA
关键词
complications; death; implantable cardioverter-defibrillators; outcome assessment; registries; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; PACEMAKER; OUTCOMES;
D O I
10.1161/CIRCULATIONAHA.110.959676
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Patients undergoing implantable cardioverter-defibrillator (ICD) implantation are at risk of postprocedural complications. However, we do not have a risk stratification schema to identify patients at high and low risk of adverse events. Methods and Results-We analyzed data from 268 701 ICD implants submitted to the ICD Registry and developed logistic regression models to identify variables most strongly associated with the risk of acute complications and/or in-hospital death. Overall, 3.2% of the population experienced an adverse event. A simple risk score consisting of 10 readily available variables successfully identified patients at high and low risk of complications. The variables included in the score and assigned points included: age >= 70 years (1 point), female (2 points), New York Heart Association class III (1 point) or IV (3 points), atrial fibrillation (1 point), prior valve surgery (3 points), chronic lung disease (2 points), blood urea nitrogen >30 (2 points), reimplantation for reasons other than battery change (6 points), ICD type dual chamber (2 points) or biventricular (4 points), and nonelective ICD implant (3 points). The risk of any in-hospital complication increased from 0.6% among patients with a score of <= 5 (8.4% of the population) to 8.4% among patients with >= 19 risk points (3.9% of the population). Conclusions-A simple risk score consisting of readily available clinical variables can identify high-and low-risk subsets of patients undergoing ICD implantation. This information can guide the physician in patient selection and determining the intensity of care required post procedure. (Circulation. 2011;123:2069-2076.)
引用
收藏
页码:2069 / 2076
页数:8
相关论文
共 50 条
  • [1] The Relation Between Hospital Procedure Volume and Complications of Cardioverter-Defibrillator Implantation From the Implantable Cardioverter-Defibrillator Registry
    Freeman, James V.
    Wang, Yongfei
    Curtis, Jeptha P.
    Heidenreich, Paul A.
    Hlatky, Mark A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (14) : 1133 - 1139
  • [2] The implantable cardioverter-defibrillator
    Raj, SR
    Sheldon, RS
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2001, 44 (03) : 169 - 194
  • [3] The implantable cardioverter-defibrillator
    Groh, WJ
    Foreman, LD
    Zipes, DP
    [J]. AMERICAN FAMILY PHYSICIAN, 1998, 57 (02) : 310 - 312
  • [4] The implantable cardioverter-defibrillator
    Greene, HL
    [J]. CLINICAL CARDIOLOGY, 2000, 23 (05) : 315 - 326
  • [5] COMPLICATIONS WITH THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    PLATIA, EV
    GRIFFITH, LSC
    REID, PR
    GUARNIERI, T
    WATKINS, L
    MOWER, MM
    MIROWSKI, M
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (02) : A200 - A200
  • [6] Successful extravascular implantable cardioverter-defibrillator implantation in a patient with recurrent transvenous implantable cardioverter-defibrillator erosion
    Robinson, Andrea
    Billakanty, Sreedhar
    Fu, Eugene
    Amin, Anish
    [J]. HEART RHYTHM O2, 2024, 5 (04): : 243 - 245
  • [7] Implantable Cardioverter-Defibrillator Interference After LVAD Implantation
    Galand, Vincent
    Leclercq, Christophe
    Boule, Stephane
    Mondoly, Pierre
    Ploux, Sylvain
    Defaye, Pascal
    Verdonk, Constance
    Pozzi, Matteo
    Lellouche, Nicolas
    Martins, Raphael P.
    [J]. JACC-CLINICAL ELECTROPHYSIOLOGY, 2020, 6 (10) : 1315 - 1317
  • [8] Testing the implantable cardioverter-defibrillator after implantation -: Is it necessary?
    Sandstedt, Bengt
    Gottfridsson, Christer
    Nystrom, Britta
    Edvardsson, Nils
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2007, 30 (08): : 985 - 991
  • [9] Survival After Implantable Cardioverter-Defibrillator Implantation in the Elderly
    Yung, Derek
    Birnie, David
    Dorian, Paul
    Healey, Jeffrey S.
    Simpson, Christopher S.
    Crystal, Eugene
    Krahn, Andrew D.
    Khaykin, Yaariv
    Cameron, Douglas
    Chen, Zhongliang
    Lee, Douglas S.
    [J]. CIRCULATION, 2013, 127 (24) : 2383 - 2392
  • [10] Benefits of the implantable cardioverter-defibrillator
    Epstein, Andrew E.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (14) : 1122 - 1127